Bio-Techne

Company Overview

Bio-Techne develops life science reagents, analytical instruments, and diagnostic products used in research and clinical laboratory settings. It manages its business under two operating segments, protein sciences and diagnostics and spatial biology (formerly diagnostics and genomics), which together support workflows spanning basic research, translational studies, and diagnostic testing.

In the protein labeling market, Bio-Techne supplies antibody- and protein-based reagents for labeling, detecting, and quantifying proteins across various applications, including immunoassays, flow cytometry, and cell and tissue imaging. Its portfolio includes fluorophore- and enzyme-conjugated primary antibodies, secondary antibodies with label options tailored to various detection methods, and fluorescently labeled immunological techniques, offered through brands such as R&D Systems and Novus Biologicals. It also provides workflow-linked platforms and reagents that rely on labeled immunodetection, including simple Western automated capillary Western systems and simple plex immunoassays, supported by associated reagents and analysis tools.

Financial Highlights (FY 2025)

Company's Business Segments

• Protein Sciences : Proteomic analytical tools, both manual and automated, developer and manufacturer of high-quality biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy.
• Diagnostics and Genomics : Develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications.